CJN-61848-85736
2 vaccinations
8 coded responses
12 check-ins
8 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 206 / MD
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Moderna
- 2021-01-27
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · HeadacheFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — days 1–6 daily, dose 1MedDRA: Exercise tolerance decreased, Fatigue — Feeling: Good · Fatigue or tirednessFree text: Quickly exhausted when I take s short walk.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Survey response — day 7, dose 1MedDRA: Headache — Feeling: Good · HeadacheFree text: Mild headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Dose 2 — Moderna
-
2021-02-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Cough — Feeling: GoodFree text: Dry coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Cough — Feeling: Fair · Fatigue or tirednessFree text: Dry coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-14
-
2021-05-28
Survey response — 3 months, dose 2MedDRA: Exposure to SARS-CoV-2, Headache, Pruritus, SARS-CoV-2 test negative, Upper-airway cough syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I was exposed to a COVID-19 person at work for 90 minutes. I had intense headache for 3 hours; After 3 days intense itching and post nasal discharge.I was then officially informed about the exposure. A convid-19 test turned out NEGATIVE.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-28
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-29
-
2022-02-26
Survey response — 12 months, dose 2MedDRA: Exposure to SARS-CoV-2, Pruritus — Feeling: GoodFree text: I was exposed to people with Covid-19's. My body in two days started itching like someone recovering from malaria. This happened twice.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-02-26 | Moderna |
Call center
1 call center case
1 successful
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): No
Systemic reaction (other): None
Systemic reaction (other): Quickly exhausted when I take s short walk.
Release 3 — day 7, dose 1
Systemic reaction (other): Mild headache
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dry cough
Systemic reaction (other): Dry cough
Release 8 — 3 months, dose 2
Symptoms: I was exposed to a COVID-19 person at work for 90 minutes. I had intense headache for 3 hours; After 3 days intense itching and post nasal discharge.I was then officially informed about the exposure. A convid-19 test turned out NEGATIVE.
Release 11 — 12 months, dose 2
Symptoms: I was exposed to people with Covid-19's. My body in two days started itching like someone recovering from malaria. This happened twice.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Exercise tolerance decreased | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release